» Articles » PMID: 31474999

Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue

Abstract

Pregnancy is a naturally occurring disease modifier of multiple sclerosis (MS) associated with a substantial reduction in relapse rate. To date, attempts to explain this phenomenon have focused on systemic maternal immune cell composition, with contradictory results. To address this matter, we compared the immunomodulatory effects of pregnancy on five leukocyte populations (i.e., CD4 and CD8 T cells, CD4CD127CD25 regulatory T cells, CD56CD16 NK cells, and CD14CD163 monocytes) in peripheral blood from different cohorts of MS patients and healthy women at different times of gestation, as well as in decidual samples from the placenta of MS patients and healthy women collected after delivery. For the first time to our knowledge, we observed that the frequency of these cell populations in the decidua is not different between MS patients and healthy women, suggesting that a physiological immune regulation may occur at the fetal-maternal interface. In peripheral blood, however, contrary to healthy women, in MS patients cell frequencies were not significantly altered by gestation. In particular, CD8 T cells did not show differences between groups. CD4 T cells were higher in non-pregnant MS compared to healthy women, while during pregnancy they remained constant in MS and increased in healthy women. Regulatory T cells were higher in non-pregnant controls compared to MS women, while the difference was reduced during gestation due to the decrease of regulatory T cell levels in healthy women. CD14CD163 monocytes did not show differences between groups. CD56CD16 NK cells were not significantly different in non-pregnant MS compared to controls and increased in healthy women during gestation. In conclusion, our findings support the hypothesis that disease amelioration in MS patients during pregnancy may be due to a modulation of the immune cells functional activity rather than their frequency. Further studies exploring functional changes of these cells would be crucial to bring light into the complex mechanisms of pregnancy-induced tolerance and autoimmunity overall.

Citing Articles

Prominent epigenetic and transcriptomic changes in CD4 and CD8 T cells during and after pregnancy in women with multiple sclerosis and controls.

Zenere A, Hellberg S, Papapavlou Lingehed G, Svenvik M, Mellergard J, Dahle C J Neuroinflammation. 2023; 20(1):98.

PMID: 37106402 PMC: 10134602. DOI: 10.1186/s12974-023-02781-2.


Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations.

Hofer S, Hofstatter N, Punz B, Hasenkopf I, Johnson L, Himly M Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 14(6):e1804.

PMID: 36416020 PMC: 9787548. DOI: 10.1002/wnan.1804.


Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy.

Papapavlou Lingehed G, Hellberg S, Huang J, Khademi M, Kockum I, Carlsson H Front Immunol. 2022; 13:930947.

PMID: 35967338 PMC: 9373039. DOI: 10.3389/fimmu.2022.930947.


Alterations of NK Cell Phenotype During Pregnancy in Multiple Sclerosis.

Wisgalla A, Ramien C, Streitz M, Schlickeiser S, Lupu A, Diemert A Front Immunol. 2022; 13:907994.

PMID: 35860238 PMC: 9289470. DOI: 10.3389/fimmu.2022.907994.


New Paradigm in Cell Therapy Using Sperm Head to Restore Brain Function and Structure in Animal Model of Alzheimer's Disease: Support for Boosting Constructive Inflammation . Anti-Inflammatory Approach.

Pakravan N, Abbasi A, Hassan Z J Immunol Res. 2022; 2022:8343763.

PMID: 35571563 PMC: 9095412. DOI: 10.1155/2022/8343763.


References
1.
. Natural killer cells and pregnancy. Nat Rev Immunol. 2002; 2(9):656-63. DOI: 10.1038/nri886. View

2.
Veenstra van Nieuwenhoven A, Heineman M, Faas M . The immunology of successful pregnancy. Hum Reprod Update. 2003; 9(4):347-57. DOI: 10.1093/humupd/dmg026. View

3.
Viglietta V, Baecher-Allan C, Weiner H, Hafler D . Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med. 2004; 199(7):971-9. PMC: 2211881. DOI: 10.1084/jem.20031579. View

4.
Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P . Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain. 2004; 127(Pt 6):1353-60. DOI: 10.1093/brain/awh152. View

5.
Al-Shammri S, Rawoot P, Azizieh F, AbuQoora A, Hanna M, Saminathan T . Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci. 2004; 222(1-2):21-7. DOI: 10.1016/j.jns.2004.03.027. View